BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 15917544)

  • 21. Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus.
    Koort JK; Mäkinen TJ; Suokas E; Veiranto M; Jalava J; Knuuti J; Törmälä P; Aro HT
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1502-8. PubMed ID: 15793132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo efficacies of teicoplanin-loaded calcium sulfate for treatment of chronic methicillin-resistant Staphylococcus aureus osteomyelitis.
    Jia WT; Luo SH; Zhang CQ; Wang JQ
    Antimicrob Agents Chemother; 2010 Jan; 54(1):170-6. PubMed ID: 19917757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Development of gentamicin-resistant Small Colony Variants of S. aureus after implantation of gentamicin chains in osteomyelitis as a possible cause of recurrence].
    von Eiff C; Lindner N; Proctor RA; Winkelmann W; Peters G
    Z Orthop Ihre Grenzgeb; 1998; 136(3):268-71. PubMed ID: 9736990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PMMA bead versus parenteral treatment of Staphylococcus aureus osteomyelitis.
    Heard GS; Oloff LM; Wolfe DA; Little MD; Prins DD
    J Am Podiatr Med Assoc; 1997 Apr; 87(4):153-64. PubMed ID: 9110526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the efficacy of tigecycline and teicoplanin in an experimental methicillin-resistant Staphylococcus aureus osteomyelitis model.
    Kandemir O; Oztuna V; Colak M; Akdag A; Camdeviren H
    J Chemother; 2008 Feb; 20(1):53-7. PubMed ID: 18343744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergy of HBO2 and a local antibiotic carrier for experimental osteomyelitis due to Staphylococcus aureus in rats.
    Mendel V; Simanowski HJ; Scholz HCh
    Undersea Hyperb Med; 2004; 31(4):407-16. PubMed ID: 15686272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus treated with a polylactide carrier releasing linezolid.
    Tsiolis P; Giamarellos-Bourboulis EJ; Mavrogenis AF; Savvidou O; Lallos SN; Frangia K; Lazarettos I; Nikolaou V; Efstathopoulos NE
    Surg Infect (Larchmt); 2011 Apr; 12(2):131-5. PubMed ID: 21348763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local treatment of chronic osteomyelitis with surgical debridement and tigecycline-impregnated calcium hydroxyapatite: an experimental study.
    Kaya M; Şimşek-Kaya G; Gürsan N; Kireççi E; Dayi E; Gündoğdu B
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Mar; 113(3):340-7. PubMed ID: 22676826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vancomycin-impregnated calcium phosphate cement for methicillin-resistant Staphylococcus aureus femoral osteomyelitis.
    Niikura T; Tsujimoto K; Yoshiya S; Tadokoro K; Kurosaka M; Shiba R
    Orthopedics; 2007 Apr; 30(4):320-1. PubMed ID: 17424700
    [No Abstract]   [Full Text] [Related]  

  • 30. A novel, multi-barrier, drug eluting calcium sulfate/biphasic calcium phosphate biodegradable composite bone cement for treatment of experimental MRSA osteomyelitis in rabbit model.
    Mistry S; Roy S; Maitra NJ; Kundu B; Chanda A; Datta S; Joy M
    J Control Release; 2016 Oct; 239():169-81. PubMed ID: 27582374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PMMA is superior to hydroxyapatite for colony reduction in induced osteomyelitis.
    Zelken J; Wanich T; Gardner M; Griffith M; Bostrom M
    Clin Orthop Relat Res; 2007 Sep; 462():190-4. PubMed ID: 17514008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis.
    Jacqueline C; Amador G; Caillon J; Le Mabecque V; Batard E; Miègeville AF; Biek D; Ge Y; Potel G; Hamel A
    J Antimicrob Chemother; 2010 Aug; 65(8):1749-52. PubMed ID: 20530506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic potential of dalbavancin in a rat model of methicillin-resistant Staphylococcus aureus (MRSA)-osteomyelitis.
    Silva V; Miranda C; Antão HS; Guimarães J; Prada J; Pires I; Maltez L; Pereira JE; Capelo JL; Igrejas G; Poeta P
    Int J Antimicrob Agents; 2020 Jul; 56(1):106021. PubMed ID: 32439480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of experimental osteomyelitis with antibiotic-impregnated bone graft substitute.
    Cornell CN; Tyndall D; Waller S; Lane JM; Brause BD
    J Orthop Res; 1993 Sep; 11(5):619-26. PubMed ID: 8410460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Staphylococcus aureus develops increased resistance to antibiotics by forming dynamic small colony variants during chronic osteomyelitis.
    Tuchscherr L; Kreis CA; Hoerr V; Flint L; Hachmeister M; Geraci J; Bremer-Streck S; Kiehntopf M; Medina E; Kribus M; Raschke M; Pletz M; Peters G; Löffler B
    J Antimicrob Chemother; 2016 Feb; 71(2):438-48. PubMed ID: 26589581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apatite cement containing antibiotics: efficacy in treating experimental osteomyelitis.
    Sasaki S; Ishii Y
    J Orthop Sci; 1999; 4(5):361-9. PubMed ID: 10542040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioerodible polyanhydrides for antibiotic drug delivery: in vivo osteomyelitis treatment in a rat model system.
    Laurencin CT; Gerhart T; Witschger P; Satcher R; Domb A; Rosenberg AE; Hanff P; Edsberg L; Hayes W; Langer R
    J Orthop Res; 1993 Mar; 11(2):256-62. PubMed ID: 8483038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Examination of a novel, specified local antibiotic therapy through polymethylmethacrylate capsules in a rabbit osteomyelitis model.
    Börzsei L; Mintál T; Koós Z; Kocsis B; Helyes Z; Kereskai L; Nyárády J
    Chemotherapy; 2006; 52(2):73-9. PubMed ID: 16567940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of fosfomycin + vancomycin or gentamicin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA).
    Olay T; Vicente MV; Rodríguez A
    J Chemother; 1989 Jul; 1(4 Suppl):391-2. PubMed ID: 16312454
    [No Abstract]   [Full Text] [Related]  

  • 40. Vancomycin-loaded nano-hydroxyapatite pellets to treat MRSA-induced chronic osteomyelitis with bone defect in rabbits.
    Jiang JL; Li YF; Fang TL; Zhou J; Li XL; Wang YC; Dong J
    Inflamm Res; 2012 Mar; 61(3):207-15. PubMed ID: 22159524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.